REG - PureTech Health PLC - Transaction in Own Shares
31/01/2024 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240131:nRSe4351Ba&default-theme=true
RNS Number : 4351B PureTech Health PLC 31 January 2024
31 January 2024
PureTech Health plc
Transaction in Own Shares
PureTech Health PLC (the "Company") announces that it has purchased the
following number of its ordinary shares of one pence each through Jefferies
International Limited ("Jefferies"), as part of its Share Buyback Programme,
details of which were announced on 9 May 2022.
Date of purchase: 30 January 2024
Number of ordinary shares purchased: 58,677
Highest price paid per share: 201.50p
Lowest price paid per share: 195.20p
Volume weighted average price paid per share: 198.31p
PureTech intends to retain the purchased shares in treasury.
Following the above transaction, the Company will have 19,116,082 ordinary
shares in treasury and has 270,352,077 ordinary shares in issue (excluding
treasury shares). The total number of voting rights in the Company is
therefore 270,352,077 which may be used by shareholders in their calculations
to determine if they are required to notify their interest in, or a change to
their interest in, PureTech Health plc under the FCA's Disclosure Guidance and
Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as
incorporated into UK domestic law by the European Union (Withdrawal) Act 2018)
(the Market Abuse Regulation), detailed information about the individual
purchases is available below.
About PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated to giving life
to new classes of medicine to change the lives of patients with devastating
diseases. The Company has created a broad and deep pipeline through its
experienced research and development team and its extensive network of
scientists, clinicians and industry leaders that is being advanced both
internally and through its Founded Entities. PureTech's R&D engine has
resulted in the development of 27 therapeutics and therapeutic candidates,
including two (Plenity® and EndeavorRx®) that have received both U.S.
FDA clearance and European marketing authorization and a third (KarXT) that
has been filed for FDA approval. A number of these programs are being advanced
by PureTech or its Founded Entities in various indications and stages of
clinical development, including registration enabling studies. All of the
underlying programs and platforms that resulted in this pipeline of
therapeutic candidates were initially identified or discovered and then
advanced by the PureTech team through key validation points.
For more information, visit www.puretechhealth.com
(http://www.puretechhealth.com/) or connect with us on X, formerly known as
Twitter, @puretechh.
Contact:
PureTech
Investor Relations
IR@puretechhealth.com
Individual Transactions
Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
30/01/2024 08:19:43 988 201 XLON 00387754716TRLO0.1.1
30/01/2024 08:22:06 205 200.5 XLON 00387755474TRLO0.1.1
30/01/2024 08:33:54 1976 201.5 XLON 00387758762TRLO0.1.1
30/01/2024 08:33:54 131 201.5 TRQX 00387758763TRLO0.1.1
30/01/2024 08:35:21 246 201 AQXE 00387759255TRLO0.1.1
30/01/2024 08:35:21 494 201 CHIX 00387759256TRLO0.1.1
30/01/2024 08:35:21 494 201 CHIX 00387759257TRLO0.1.1
30/01/2024 08:35:21 1277 201 XLON 00387759258TRLO0.1.1
30/01/2024 08:35:26 494 200.5 BATE 00387759300TRLO0.1.1
30/01/2024 08:39:25 494 200 XLON 00387760551TRLO0.1.1
30/01/2024 08:50:26 83 199.2 XLON 00387763066TRLO0.1.1
30/01/2024 08:50:26 411 199.2 XLON 00387763067TRLO0.1.1
30/01/2024 08:50:26 428 199.2 XLON 00387763068TRLO0.1.1
30/01/2024 08:50:26 66 199.2 XLON 00387763069TRLO0.1.1
30/01/2024 08:56:16 494 199 XLON 00387764083TRLO0.1.1
30/01/2024 08:56:30 130 199 XLON 00387764131TRLO0.1.1
30/01/2024 08:56:30 380 198.8 XLON 00387764132TRLO0.1.1
30/01/2024 09:19:11 494 198.4 BATE 00387768816TRLO0.1.1
30/01/2024 09:19:11 90 198.4 BATE 00387768817TRLO0.1.1
30/01/2024 09:19:11 478 198.4 XLON 00387768818TRLO0.1.1
30/01/2024 09:19:11 135 198.4 XLON 00387768819TRLO0.1.1
30/01/2024 09:19:11 359 198.4 XLON 00387768820TRLO0.1.1
30/01/2024 09:19:11 494 198.4 XLON 00387768821TRLO0.1.1
30/01/2024 09:19:32 134 197.8 CHIX 00387768902TRLO0.1.1
30/01/2024 09:19:32 360 197.8 CHIX 00387768903TRLO0.1.1
30/01/2024 09:59:19 246 198 AQXE 00387776513TRLO0.1.1
30/01/2024 09:59:19 494 198 CHIX 00387776512TRLO0.1.1
30/01/2024 09:59:19 131 198 TRQX 00387776514TRLO0.1.1
30/01/2024 09:59:19 494 198 XLON 00387776515TRLO0.1.1
30/01/2024 09:59:19 990 198 XLON 00387776516TRLO0.1.1
30/01/2024 09:59:19 986 198 XLON 00387776517TRLO0.1.1
30/01/2024 09:59:24 107 197.2 BATE 00387776582TRLO0.1.1
30/01/2024 09:59:24 67 197.2 BATE 00387776580TRLO0.1.1
30/01/2024 10:02:38 59 197.2 BATE 00387777718TRLO0.1.1
30/01/2024 10:06:08 31 197.2 BATE 00387778281TRLO0.1.1
30/01/2024 10:07:04 30 197.2 BATE 00387778397TRLO0.1.1
30/01/2024 10:09:53 1 197.2 BATE 00387778862TRLO0.1.1
30/01/2024 10:09:53 109 197.2 BATE 00387778863TRLO0.1.1
30/01/2024 10:09:53 84 197.2 BATE 00387778865TRLO0.1.1
30/01/2024 10:09:53 264 197.2 BATE 00387778864TRLO0.1.1
30/01/2024 10:11:29 1244 197 XLON 00387779158TRLO0.1.1
30/01/2024 10:11:29 131 197 TRQX 00387779159TRLO0.1.1
30/01/2024 10:11:29 732 197 XLON 00387779160TRLO0.1.1
30/01/2024 10:41:45 1482 196.6 XLON 00387790146TRLO0.1.1
30/01/2024 10:41:46 988 196.6 XLON 00387790149TRLO0.1.1
30/01/2024 11:01:25 9 196 AQXE 00387795688TRLO0.1.1
30/01/2024 11:25:49 237 196 AQXE 00387802101TRLO0.1.1
30/01/2024 11:25:49 246 196 AQXE 00387802100TRLO0.1.1
30/01/2024 11:25:49 131 196 TRQX 00387802102TRLO0.1.1
30/01/2024 11:25:49 1976 196 XLON 00387802103TRLO0.1.1
30/01/2024 11:25:49 550 195.2 BATE 00387802104TRLO0.1.1
30/01/2024 11:25:49 74 195.2 BATE 00387802105TRLO0.1.1
30/01/2024 11:25:49 365 195.2 CHIX 00387802106TRLO0.1.1
30/01/2024 11:25:49 16 195.2 BATE 00387802107TRLO0.1.1
30/01/2024 11:25:54 9 196 XLON 00387802122TRLO0.1.1
30/01/2024 11:25:54 354 196 XLON 00387802123TRLO0.1.1
30/01/2024 11:26:59 25 196 XLON 00387802420TRLO0.1.1
30/01/2024 11:33:38 385 196 XLON 00387804371TRLO0.1.1
30/01/2024 11:33:38 311 196 XLON 00387804372TRLO0.1.1
30/01/2024 12:44:07 18 195.2 BATE 00387822870TRLO0.1.1
30/01/2024 12:49:11 453 196 XLON 00387824722TRLO0.1.1
30/01/2024 13:30:05 9 195.4 AQXE 00387834713TRLO0.1.1
30/01/2024 13:50:26 131 196.8 TRQX 00387840429TRLO0.1.1
30/01/2024 14:17:04 41 197 XLON 00387850076TRLO0.1.1
30/01/2024 14:17:04 246 197 AQXE 00387850075TRLO0.1.1
30/01/2024 14:17:04 747 197 XLON 00387850077TRLO0.1.1
30/01/2024 14:17:04 254 197 XLON 00387850078TRLO0.1.1
30/01/2024 14:17:04 131 197 TRQX 00387850080TRLO0.1.1
30/01/2024 14:17:04 934 197 XLON 00387850079TRLO0.1.1
30/01/2024 14:30:03 303 198.8 XLON 00387855041TRLO0.1.1
30/01/2024 14:31:29 100 198.6 XLON 00387856310TRLO0.1.1
30/01/2024 14:53:45 3 198.8 CHIX 00387868446TRLO0.1.1
30/01/2024 14:54:38 246 198.2 AQXE 00387868821TRLO0.1.1
30/01/2024 14:54:38 246 198.2 AQXE 00387868822TRLO0.1.1
30/01/2024 14:54:38 131 198.2 TRQX 00387868823TRLO0.1.1
30/01/2024 14:54:38 2470 198.2 XLON 00387868824TRLO0.1.1
30/01/2024 14:54:38 131 198 TRQX 00387868825TRLO0.1.1
30/01/2024 14:54:45 123 198.4 CHIX 00387868865TRLO0.1.1
30/01/2024 14:54:45 106 198.4 CHIX 00387868866TRLO0.1.1
30/01/2024 14:54:45 391 198.6 CHIX 00387868867TRLO0.1.1
30/01/2024 14:54:45 350 198.8 CHIX 00387868868TRLO0.1.1
30/01/2024 14:55:02 35 198.4 BATE 00387868996TRLO0.1.1
30/01/2024 14:55:38 90 198.4 CHIX 00387869355TRLO0.1.1
30/01/2024 14:56:10 46 198.4 CHIX 00387869709TRLO0.1.1
30/01/2024 14:58:51 5580 199 XLON 00387871014TRLO0.1.1
30/01/2024 15:01:40 866 199.2 XLON 00387872765TRLO0.1.1
30/01/2024 15:03:02 12 198.6 AQXE 00387873913TRLO0.1.1
30/01/2024 15:06:59 95 198.6 AQXE 00387875706TRLO0.1.1
30/01/2024 15:08:43 460 199.2 XLON 00387876632TRLO0.1.1
30/01/2024 15:10:15 100 199.2 XLON 00387877502TRLO0.1.1
30/01/2024 15:10:17 2 199.2 CHIX 00387877511TRLO0.1.1
30/01/2024 15:12:05 13 198.6 AQXE 00387878410TRLO0.1.1
30/01/2024 15:15:04 117 198.6 AQXE 00387880083TRLO0.1.1
30/01/2024 15:15:05 15 199.2 XLON 00387880089TRLO0.1.1
30/01/2024 15:25:34 410 199.2 XLON 00387886172TRLO0.1.1
30/01/2024 15:40:57 800 199.2 XLON 00387894311TRLO0.1.1
30/01/2024 15:40:58 455 199.2 CHIX 00387894314TRLO0.1.1
30/01/2024 15:41:03 800 199.2 XLON 00387894379TRLO0.1.1
30/01/2024 15:51:45 10 198.4 AQXE 00387900310TRLO0.1.1
30/01/2024 15:56:32 42 198.4 AQXE 00387902910TRLO0.1.1
30/01/2024 15:56:32 194 198.4 AQXE 00387902911TRLO0.1.1
30/01/2024 15:56:32 131 198.4 TRQX 00387902913TRLO0.1.1
30/01/2024 15:56:32 108 198.4 AQXE 00387902912TRLO0.1.1
30/01/2024 15:56:32 40 198.4 TRQX 00387902914TRLO0.1.1
30/01/2024 15:56:32 29 198.4 TRQX 00387902915TRLO0.1.1
30/01/2024 15:56:32 79 198.4 XLON 00387902916TRLO0.1.1
30/01/2024 15:56:32 222 198.4 XLON 00387902917TRLO0.1.1
30/01/2024 15:56:32 957 198.4 XLON 00387902918TRLO0.1.1
30/01/2024 15:56:32 1212 198.4 XLON 00387902919TRLO0.1.1
30/01/2024 15:56:33 494 198 CHIX 00387902926TRLO0.1.1
30/01/2024 15:56:33 494 198 CHIX 00387902927TRLO0.1.1
30/01/2024 15:59:10 12 197.6 BATE 00387904266TRLO0.1.1
30/01/2024 15:59:10 77 197.6 BATE 00387904267TRLO0.1.1
30/01/2024 15:59:10 405 197.6 BATE 00387904268TRLO0.1.1
30/01/2024 15:59:11 519 197.8 CHIX 00387904276TRLO0.1.1
30/01/2024 15:59:11 2470 197.2 XLON 00387904277TRLO0.1.1
30/01/2024 15:59:13 9 197.2 CHIX 00387904343TRLO0.1.1
30/01/2024 16:02:56 354 198 XLON 00387907362TRLO0.1.1
30/01/2024 16:09:49 435 198.2 XLON 00387911189TRLO0.1.1
30/01/2024 16:09:53 215 198.2 CHIX 00387911230TRLO0.1.1
30/01/2024 16:09:55 79 198.2 XLON 00387911236TRLO0.1.1
30/01/2024 16:09:55 1268 198.2 XLON 00387911237TRLO0.1.1
30/01/2024 16:09:59 26 198.2 XLON 00387911278TRLO0.1.1
30/01/2024 16:09:59 98 198.2 XLON 00387911279TRLO0.1.1
30/01/2024 16:10:31 3 198.2 XLON 00387911599TRLO0.1.1
30/01/2024 16:10:42 354 198.2 XLON 00387911683TRLO0.1.1
30/01/2024 16:11:03 350 198.2 XLON 00387911917TRLO0.1.1
30/01/2024 16:11:41 12 198.2 XLON 00387912289TRLO0.1.1
30/01/2024 16:12:41 422 198.2 XLON 00387912792TRLO0.1.1
30/01/2024 16:14:18 351 198.2 XLON 00387913728TRLO0.1.1
30/01/2024 16:14:51 127 198.2 CHIX 00387914045TRLO0.1.1
30/01/2024 16:14:51 700 198.2 CHIX 00387914046TRLO0.1.1
30/01/2024 16:18:14 437 198.4 XLON 00387916024TRLO0.1.1
30/01/2024 16:18:14 124 198.4 XLON 00387916025TRLO0.1.1
30/01/2024 16:18:23 196 198.8 XLON 00387916156TRLO0.1.1
30/01/2024 16:18:29 124 198.8 XLON 00387916251TRLO0.1.1
30/01/2024 16:21:40 2400 198.8 XLON 00387918996TRLO0.1.1
30/01/2024 16:24:15 430 198.4 CHIX 00387920473TRLO0.1.1
30/01/2024 16:28:48 109 198.8 CHIX 00387923199TRLO0.1.1
30/01/2024 16:29:47 37 198.8 CHIX 00387924085TRLO0.1.1
30/01/2024 16:29:47 369 198.8 CHIX 00387924086TRLO0.1.1
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSFLFITLAIIVISRecent news on Puretech Health
See all newsREG - PureTech Health PLC - Total Voting Rights
AnnouncementREG - PureTech Health PLC - Final Results
AnnouncementREG - PureTech Health PLC - Notice of Results
AnnouncementRCS - PureTech Health PLC - PRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024
AnnouncementRCS - PureTech Health PLC - FDA Grants PRTC's LYT-200 Fast Track Designation
Announcement